Skip to content Skip to footer
Subscribe Now
THOUGHTSPOT

Pharma Market Access Conferences 2026: Where Commercial Teams Meet the Decision-Makers

The pharma market access conferences worth a commercial team's time in 2026 share one trait: they put market access, HEOR, and medical affairs leaders in the same room as the payers and health system executives who actually control access.   Reaching prescribers is not the same as winning system adoption, and the events below are where that second, harder conversation…
June 19, 2026

Read more

VIEWPOINTS_Gavin Magaha_2024
VIEWPOINTS

Drug Discount Solutions: Gavin Magaha from Kalderos, in a Stimulating Conversation with PharmaShots

Shots:  With the implementation of the Inflation Reduction Act (IRA) in 2022, several pricing reforms were introduced, including the new mandated drug pricing and discount elements  Today, we have with us Gavin Magaha, Senior Director, Value Delivery for Kalderos, shedding light on the challenges that come with the IRA act and the impact it puts on…
May 20, 2024

Read more

VIEWPOINTS_Kyle Forcier_2023
VIEWPOINTS

In a gripping conversation with PharmaShots, Kyle Forcier addresses the ways to avoid the challenges of the 340B program

Shots:  Kyle Forcier, Sr. Director of Life Science Product Marketing at Model N, addresses the challenges of the 340B program and ways manufacturers can mitigate them and emerge stronger   340B, a US federal government plan, enables eligible healthcare organizations and covered entities to receive outpatient drugs from drug manufacturers at significantly low prices   Kyle recalls…
October 23, 2023

Read more